|
I.S. Romanov
POTENTIALS FOR THE MODERN CHEMOTHERAPY OF HIGH DIFFERENTIATED THYROID CARCINOMA
|
8-12 |
|
Yu.Yu. Andreeva, L.E. Zavalishina, N.V. Danilova, M.E. Ilatovskaya, G.A. Frank
METHODOLOGICAL ASPECTS OF MORPHOLOGICAL DIAGNOSIS AND EVALUATION OF THERAPEUTIC PATHOMORPHOSIS OF TRIPLE NEGATIVE BREAST CANCER
|
13-18 |
|
V.A. Gorbunova
PROMISING NEW DRUGS FOR THE TREATMENT OF HER2-POSITIVE BREAST CANCER
|
19-28 |
|
M.E. Abramov (1), K.S. Lodygina (2)
PALONOSETRON FOR THE PREVENTION OF NAUSEA AND VOMITING DURING HIGHLY AND MODERATELY EMETOGENIC CHEMOTHERAPY
|
29-34 |
|
A.D. Kaprin, B.Ya. Alekseev, K .M. Nyushko, A.S. Kalpinsky
MODERN APPROACHES TO DRUG THERAPY OF PATIENTS WITH METASTATIC CASTRATION- REFRACTORY PROSTATE CANCER
|
35-39 |
|
V.V. Breder, K.K. Laktionov
ALK-POSITIVE NONSMALL CELL LUNG CANCER: NEW PATIENTS AND NEW POTENTIALS FOR THE DRUG TREATMENT
|
40-45 |
|
V.A. Gorbunova
EVEROLIMUS (AFINITOR): NEW POTENTIALS FOR THE THERAPY OF MALIGNANT TUMORS
|
46-52 |
|
M.V. Zabelin (1, 2), DB Sidorov (1, 2), A.S. Safonov (1)
ROLE OF LIPOSUCTION IN THE TREATMENT OF POSTMASTECTOMIC LYMPHEDEMA
|
53-56 |
|
A.D. Darenskaya , N.V. Dobrova
NEW REGIMEN OF FIRST-LINE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER
|
57-61 |
|
N.N. Semenov
BONDRONAT – THE EXPERIENCE OF USE IN PATIENTS WITH BONE METASTASIS FROM BREAST CANCER
|
62-64 |
|
N.A. Falaleeva
MANTLE CELL LYMPHOMA IN THE ELDERLY AGE
|
65-70 |
|
E.V. Chernoglazova
PREOPERATIVE CHEMOTHERAPY FOR RESECTABLE COLORECTAL LIVER METASTASES
|
71-74 |
|
I.P. Ganshina, E.V. Lubennikova, L.G. Zhukova
DUAL HER2 BLOCKADE - A NEW DIRECTION IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER
|
75-79 |
Русский
